The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.

Saved in:
Bibliographic Details
Title: The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: a substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial.
Authors: Giles TD; Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA. tgiles@lsuhsc.edu, Kerut EK, Roffidal LE, Jones R, Given MB, Hutchinson H, Tresznewsky O
Source: Blood pressure monitoring [Blood Press Monit] 2001 Apr; Vol. 6 (2), pp. 81-4.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9606438 Publication Model: Print Cited Medium: Print ISSN: 1359-5237 (Print) Linking ISSN: 13595237 NLM ISO Abbreviation: Blood Press Monit Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1359-5237
DOI:10.1097/00126097-200104000-00003